Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Owen Dempsey
View:
Post by Mole101 on May 25, 2021 4:26pm

Owen Dempsey

I think he just made his first official decision by halting the "pre-sale" at immmunitypass , they are back to " coking soon"...Why ? I guess we can speculate:
a... Holding for the official launch of Immusafe 
b.... Waiting from HC for final approvals related to public tests
c.....?
Comment by Gbathat on May 26, 2021 7:48am
I'm guessing B.  I think June 1 could still be the date, but that presale prior to approval might have been ill-advised, and as you noted, now corrected. Looking forward to another UP day for PMN/ARFXF!  Hopefully we gets some more PRs circa 31 May.
Comment by retiredcop on May 26, 2021 8:32am
With yesterday's announcement , it seems pretty obvious the tests are moving in different directions ... Immusafe seems to be geared to an internet styled ma4keting plan for individuals that will have costomers purchasing for genuine need to know if and what immunity protection they have right up to the person that just buys because it's available.  PMN S TEST is geared to the needs ...more  
Comment by Mole101 on May 26, 2021 8:47am
Thank you for that information RC.. I have a question ,.. if that is the case and we have two test caitering to two different sectors. Will the profits be split 50/50 as per the JV ? Because that would be maximizing revenues and reach   
Comment by retiredcop on May 26, 2021 9:45am
Same question many of us have... I dont think we will know till we have the ability to access the actual jv agreement or someone from within answers it for us  ,, and if I was a betting man I say that will be unrealistic . Might have to wait till the quarterly financials come out and we see what income is coming in. But if the market even smells a hint of income from either coming into PMN ...more  
Comment by BottomBroker on May 26, 2021 9:19am
Agreed. I'd rather be selling to big gov't with endless $ than individuals. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities